Analysts and Recommendations – NEW
Brokerage Number: 17
Information contained on this website is updated on a regular basis. Due to the nature of some of the information posted, it becomes outdated rapidly. Please, be advised that information contained in this section of the website is not updated, and may not reflect the current situation of the Company.
| Buy/ Overperform/ Overweight/ Outperform |
17.64% |
Average (*) |
R$7.95 |
  |
| Neutral/ Hold/ In Line/ Marketperform/ Equal-weight |
52.94% |
Standard Deviation (*) |
3.02 | |
| Sell/ Underperform/ Underweight/ Market Underperform |
29.41% |
Higher (*) |
R$12.00 | |
| Under Review | – |
Lower (*) |
R$5.00 | |
| BROKER | ANALYST | TARGET PRICE (12 MONTHS) | RECOMMENDATION |
|---|---|---|---|
| Autonomous | Craig Maurer | R$5.00 | Sell |
| Banco do Brasil | Wesley Bernabé | Under Review | |
| Bank of America | Mario Pierry | R$8.50 | Hold |
| Barclays | Gerardus Vos | R$10.70 | Buy |
| Bradesco | Rafael Frade | R$8.00 | Hold |
| Brasil Plural | Eduardo Nishio | R$6.58 | Buy |
| BTG Pactual | Eduardo Rosman | R$7.00 | Hold |
| Citi | Felipe Gaspar Salomao | R$7.00 | Hold |
| Credit Suisse | Lucas Lopes | R$6.00 | Sell |
| Goldman Sachs | Tito Labrta | R$7.00 | Sell |
| Guggenheim | Jeff Cantwell | N/A | Hold |
| HSBC | Carlos Gomez-Lopez | R$11.00 | Buy |
| Itaú BBA | Thiago Bovolenta Batista | R$7,50 | Hold |
| JP Morgan | Domingos Falavina | R$8.00 | Hold |
| Morgan Stanley | Jorge Kuri | R$12.00 | Buy |
| Safra | Silvio Doria V de Carvalho | R$8.00 | Hold |
| Santander | Henrique Navarro | R$8.00 | Sell |
| UBS | Marina Taddeo | R$8.50 | Hold |
| XP Investimentos | André Martins | R$7.00 | Hold |
Updated on September 02, 2019.
Cielo is covered by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Cielo´s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Company or its management. Cielo does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. The Company does not warrant that the above list of analysts is complete nor updated, and the information herein provided is subject to the authorization of the analysts.